ANGPTL4 Antibody (Center) Blocking Peptide
€293.00
In stock
SKU
AC-BP9207c
Background:
ANGPTL4 is a member of the angiopoietin/angiopoietin-like gene family and encodes a glycosylated, secreted protein with a fibrinogen C-terminal domain. This protein is induced under hypoxic conditions in endothelial cells and is the target of peroxisome proliferation activators. The encoded protein is a serum hormone directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity and also acts as an apoptosis survival factor for vascular endothelial cells. The encoded protein may play a role in several cancers and it also has been shown to prevent the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness. Decreased expression of this protein has been associated with type 2 diabetes.
Other Names: Angiopoietin-related protein 4, Angiopoietin-like protein 4, Hepatic fibrinogen/angiopoietin-related protein, HFARP, ANGPTL4, ARP4, HFARP, PGAR
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9207c was selected from the Center region of human ANGPTL4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: Q9BY76
Gene ID: 51129
Gene Name: ANGPTL4
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Maxwell,T.J., et.al., Int J Mol Sci 11 (1), 370-385 (2010)Legry,V., et.al, J. Clin. Endocrinol. Metab. 94 (12), 5070-5077 (2009)Sonnenburg,W.K., et.al, J. Lipid Res. 50 (12), 2421-2429 (2009)
ANGPTL4 is a member of the angiopoietin/angiopoietin-like gene family and encodes a glycosylated, secreted protein with a fibrinogen C-terminal domain. This protein is induced under hypoxic conditions in endothelial cells and is the target of peroxisome proliferation activators. The encoded protein is a serum hormone directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity and also acts as an apoptosis survival factor for vascular endothelial cells. The encoded protein may play a role in several cancers and it also has been shown to prevent the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness. Decreased expression of this protein has been associated with type 2 diabetes.
Other Names: Angiopoietin-related protein 4, Angiopoietin-like protein 4, Hepatic fibrinogen/angiopoietin-related protein, HFARP, ANGPTL4, ARP4, HFARP, PGAR
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9207c was selected from the Center region of human ANGPTL4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: Q9BY76
Gene ID: 51129
Gene Name: ANGPTL4
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Maxwell,T.J., et.al., Int J Mol Sci 11 (1), 370-385 (2010)Legry,V., et.al, J. Clin. Endocrinol. Metab. 94 (12), 5070-5077 (2009)Sonnenburg,W.K., et.al, J. Lipid Res. 50 (12), 2421-2429 (2009)
| Is Featured? | No |
|---|
Write Your Own Review